BioCopy AG
BioCopy specializes in the development of multispecific T-cell engagers against pHLA targets of solid tumors using its proprietary AI-based ultra-high-throughput technology to rapidly deliver the safest possible therapeutics to patients.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}